000			03649nam a2200241Ia 4500
003			NULRC
005			20250520102958.0
008			250520s9999 xx 000 0 und d
020			_a9783319150031
040			_cNULRC
050			_aR 855.3 .A24 2015
100			_aAbellán-Peripañán, José Maria _eauthor
245		0	_aHealth technology assessment and health policy today : _ba multifaceted view of their unstable crossroads / _cJose Maria Abellan-Peripan [and ten others].
260			_aCham, Switzerland : _bSpringer International Publishing, _cc2015
300			_axvi, 156 pages : _billustrations ; _c24 cm.
365			_bUSD16.84
504			_aIncludes bibliographical references.
505			_aPart 1: Critical overview -- 1.Health technology assessment and its interface with regulation, policy and management -- 2.Health Technology Assessment (HTA) and the incentives to innovation in the life cycle of a health technology -- 3.The wisdom tooth of health technology assessment -- 4.Regaining health technology assessment from oblivion: improving and integrating regulation of drugs, medical devices, diagnostic tests and surgical innovations -- Part 2: Issues -- 5.Four issues in cost-effectiveness analysis and health technology assessment: a view from the touch-line -- 6.Measuring QALYs for HTA and health policy decision making: bridging the gap between power and ACT -- 7.What health technology assessment system do we really need?: a critical review of the curent situation of health technology assessment in five European countries -- 8.The final stretch?: how shared decision making extends health technology assessment to meet patient preference -- 9.Dissemination of health technology assessment.
520			_aThis book disentangles the issues in connection with the advancement of Health Technology Assessment (HTA) and its interface with health policy. It highlights the factors that should shape its progress in the near future. Interdisciplinary and critical views from a number of professionals are put together in a prescient order to cast some light and make recommendations as to the next steps HTA should take to be fit for purpose. A wealth of documents dealing with HTA have been published over the last three decades. HTA allegedly is one of the bedrocks of regulation and medical decision making. However, counter vailing visions contend that geographical variations in the role that HTA is actually playing within countries pinpoints specific room for improvement. Given our social preferences, cherry-picking HTA’s features and successes over the last decades moves it away from its possibility frontier. Some of the most noteworthy hindrances that HTA faces, in several countries, to making headway towards its consolidation as an efficient tool for regulation and decision making are as follows: insufficient resources, delays in assessment, inadequate priority setting, regulatory capture, public distrust, actual influence on regulatory decisions, the need for strengthening international cooperation and harmony, the lack of sound and consistent assessments of diagnostic tests, medical devices and surgical innovations and limited dissemination. Time has come for HTA to take a renewed stand. There is a pressing need to submit HTA to in-depth critical scrutiny.
650			_aMEDICAL POLICY
700			_aBanta, David;Campillo, Carlos;Culyer, Anthony J.;Drummond, Michael ;Elwyn, Glyn;Grande, Stuart W.;Del Llano, Juan Ernesto;Meneu, Ricard;Ort├║n, Vicente;Rovira, Joan _eco-author;co-author;co-author;co-author;co-author;co-author;co-author;co-author;co-author;co-author
942			_2lcc _cBK
999			_c20435 _d20435